February 09, 2021
Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease

January 11, 2021
Biopharma Executive Perspectives on 2021

December 24, 2020
A year in Longevity: science perspectives

December 1, 2020
View From The Inside: What's Shaping Biopharma In 2021 And Beyond?

October 19, 2020
HQ Move Fuels Fountain's AI Drug Discovery Machine

October 14, 2020
SMA, NMOSD and Aging – From Few to Everyone

August 31, 2020
Healthy aging – it’s still all about diet and exercise. For now

August 11, 2020
Intervening in the Aging Process to Treat Age-Associated Diseases with John Dimos Fountain Therapeutics

July 16, 2020
Targeting Diseases of Aging at a Cellular Level

July 15, 2020
Fountain Therapeutics: an AI-based platform to reverse cellular aging

July 8, 2020
Hiring During COVID-19: Business as Usual in the New Normal

June 17, 2020
Biotech Startups Look to Test Employees for Covid-19 in Bid to Get Back to Normal

June 1, 2020
Fountain’s ‘hypothesis-free’ approach to Longevity AI

May 19, 2020
Fountain fires up aging drugs platform with new $6M financing

April 23, 2020
Four medical school professors elected to American Academy of Arts and Sciences